Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.255 USD | -1.18% | -7.12% | -34.04% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.04% | 83.67M | |
+50.94% | 63.85B | |
-2.20% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.66% | 26.52B | |
-21.59% | 18.69B | |
+3.18% | 12.73B | |
+22.07% | 12.11B | |
+28.03% | 12.07B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- IO Biotech Reports 'Encouraging' Data from Phase 2 Trial of IO102-IO103, Keytruda Combination to Treat Lung Cancer